We used a general linear model with CCL22 level as the dependent variable to adjust for the effects of smoking, obesity, and olanzapine use, and in addition included a covariate for study site (HEPS or TEPS). Here, CCL22 is linked to obesity due to melanocortin 4 receptor deficiency.